These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24569312)

  • 1. Immunogenicity of Haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants.
    D'Angio CT; Murray TE; Li L; Heyne RJ; O'Shea TM; Schelonka RL; Shankaran S; Duara S; Goldberg RN; Stoll BJ; Stevenson DK; Vohr BR; Phelps DL; Carlo WA; Pichichero ME; Das A; Higgins RD;
    Pediatr Infect Dis J; 2013 Dec; 32(12):1400-2. PubMed ID: 24569312
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B.
    Anderson EL; Frey S; Geldmacher K; Radley D; Lee A; Donnelly J; Mendelman PM; Dargan JM; Kaplan KM
    Pediatr Infect Dis J; 2002 Apr; 21(4):350-2. PubMed ID: 12075771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae type b vaccines: history, choice and comparisons.
    Decker MD; Edwards KM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S113-6. PubMed ID: 9781742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
    Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
    Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
    Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease.
    Berthet F; Prehn A; Suter R; Ethevenaux C; Seger RA
    Pediatr Allergy Immunol; 1998 Aug; 9(3):156-60. PubMed ID: 9814731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled, blinded study of the safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine injected at different intramuscular sites in Chinese infants.
    Shi N; Luo F; Li L; Zheng D; Zhang Z; Wang Z; Yang L; Liu Z; Ai X; Bai Y; Lu Q
    Hum Vaccin Immunother; 2013 Nov; 9(11):2311-5. PubMed ID: 23842003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
    Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
    Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study to evaluate the safety and immunogenicity of two lots of Haemophilus influenzae type-B conjugate vaccine manufactured at different scales.
    Hirve S; Bavdekar A; Juvekar S; Agarwal D; Barde P; Mangrule S; Patwardhan M; Pandit A; Kulkarni PS
    Vaccine; 2011 Jul; 29(33):5363-7. PubMed ID: 21651947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
    Fitzwater SP; Ramachandran P; Kahn GD; Nedunchelian K; Suresh S; Santosham M; Chandran A
    Vaccine; 2019 Mar; 37(12):1608-1613. PubMed ID: 30772069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants.
    Pichichero ME; Voloshen T; Passador S
    Pediatr Infect Dis J; 1999 Dec; 18(12):1106-8. PubMed ID: 10608637
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada.
    Wenger JD
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S132-6. PubMed ID: 9781746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.
    Allali S; Chalumeau M; Launay O; Ballas SK; de Montalembert M
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011199. PubMed ID: 26881484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.
    Madhi SA; Kuwanda L; Saarinen L; Cutland C; Mothupi R; Käyhty H; Klugman KP
    Vaccine; 2005 Dec; 23(48-49):5517-25. PubMed ID: 16107294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries.
    Lagos R; Levine OS; Avendaño A; Horwitz I; Levine MM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S139-48. PubMed ID: 9781748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer.
    Hamidi A; Verdijk P; Kreeftenberg H
    Hum Vaccin Immunother; 2014; 10(9):2691-6. PubMed ID: 25483504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.
    Goldblatt D
    Arch Dis Child; 2008 Aug; 93(8):646-7. PubMed ID: 18644932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.